研究显示阿司匹林可以将特定基因突变患者的结肠癌复发率减少58%。 Study shows aspirin can reduce colorectal cancer recurrence by 58% in patients with specific gene mutations.

在2025年胃肠癌专题讨论会上进行的一项新研究表明,使用阿司匹林三年可以大大降低特定基因突变患者的结肠癌复发风险,使复发率降低58%。 A new study at the 2025 Gastrointestinal Cancers Symposium shows that using aspirin for three years can significantly lower the risk of colorectal cancer recurrence in patients with specific gene mutations, reducing recurrence by up to 58%. 涉及整个北欧各医院626名病人的ALASCA试验发现阿司匹林对患有PIK3CA和PIK3R1/PTEN突变的人特别有效。 The ALASCCA trial, involving 626 patients across Northern European hospitals, found aspirin especially effective for those with PIK3CA and PIK3R1/PTEN mutations. 这项研究可以改变医生如何治疗近三分之一的早期直肠癌患者。 This study could change how doctors treat nearly a third of early-stage colorectal cancer patients.